Skip to main content
. Author manuscript; available in PMC: 2014 Jun 18.
Published in final edited form as: Biol Blood Marrow Transplant. 2011 May 27;17(12):1841–1845. doi: 10.1016/j.bbmt.2011.05.018

Table 3.

Impact of Platelet Recovery on Overall Survival, Progression-Free Survival, and Nonrelapse Mortality for All Patients, CR1 Patients, and ≥CR2 Patients at Time of Stem Cell Transplantation

Patient Group OS
HR (P value)		 PFS
HR (P value)		 NRM
HR (P value)
CRp versus CR 2 (P < .001) 1.7 (P=.001) 1.7 (P =.03)
CR1p versus CR1 2.1 (P =.002) 1.7 (P =.02) 2.3 (P =.01)
≥CR2p versus ≥CR2 1.9 (P =.02) 1.7 (P =.05) 1.1 (P =.9)

OS indicates overall survival; PFS, progression-free survival; NRM, nonrelapse mortality; HR, hazards ratio; CRp, remission without platelet recovery; CR, complete remission; CR1p, CR1 without platelet recovery; CR1, first complete remission; ≥CR2p, equal to or greater than second complete remission without platelet recovery; ≥CR2, equal to or greater than second complete remission. Outcomes are compared at the median follow-up time: 36 months for the CR versus CRp and CR1 versus CR1p groups, and at 60 months for the ≥CR2 versus ≥CR2p groups.